Published in Infect Immun on May 01, 1996
Communication among oral bacteria. Microbiol Mol Biol Rev (2002) 4.67
Deletion of the central proline-rich repeat domain results in altered antigenicity and lack of surface expression of the Streptococcus mutans P1 adhesin molecule. Infect Immun (1998) 1.17
Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun (2000) 1.07
Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study. PLoS One (2014) 0.84
Efficient isolation of genes by using antibody probes. Proc Natl Acad Sci U S A (1983) 34.00
By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol (1991) 6.62
Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus. Int J Syst Bacteriol (1995) 5.91
Strategies for epitope analysis using peptide synthesis. J Immunol Methods (1987) 5.69
Man-made antibodies. Nature (1991) 3.88
Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol (1993) 3.36
Sequence analysis of the cloned streptococcal cell surface antigen I/II. FEBS Lett (1989) 2.11
Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries. Infect Immun (1985) 1.92
Epitope-directed processing of specific antigen by B lymphocytes. J Cell Biol (1989) 1.90
Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans. Infect Immun (1993) 1.77
Cloning and expression of a Streptococcus sanguis surface antigen that interacts with a human salivary agglutinin. Infect Immun (1988) 1.75
Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans. Infect Immun (1987) 1.70
Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol (1987) 1.58
Construction of validated, non-redundant composite protein sequence databases. Protein Eng (1990) 1.55
Cognitive features of continuous antigenic determinants. J Mol Recognit (1988) 1.52
Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis (1992) 1.50
Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology (1991) 1.49
Suppressive effect of antibody on processing of T cell epitopes. J Exp Med (1993) 1.48
Identification of viridans streptococci associated with bacteraemia in neutropenic cancer patients. J Med Microbiol (1994) 1.47
Sequence and structural analysis of surface protein antigen I/II (SpaA) of Streptococcus sobrinus. Infect Immun (1991) 1.44
An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans. Infect Immun (1990) 1.39
Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Infection (1990) 1.39
Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet (1984) 1.38
Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins. J Infect Dis (1988) 1.34
Conservation of salivary glycoprotein-interacting and human immunoglobulin G-cross-reactive domains of antigen I/II in oral streptococci. Infect Immun (1994) 1.33
A protein fragment of streptococcal cell surface antigen I/II which prevents adhesion of Streptococcus mutans. Infect Immun (1993) 1.30
Regions of the Streptococcus sobrinus spaA gene encoding major determinants of antigen I. J Bacteriol (1990) 1.30
Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in The Netherlands. Eur J Clin Microbiol Infect Dis (1991) 1.27
Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen. J Immunol (1991) 1.26
Horizontal spread of an altered penicillin-binding protein 2B gene between Streptococcus pneumoniae and Streptococcus oralis. FEMS Microbiol Lett (1993) 1.24
Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J Infect Dis (1995) 1.20
T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II. Infect Immun (1995) 1.16
Saliva-binding region of Streptococcus mutans surface protein antigen. Infect Immun (1993) 1.15
In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis (1992) 1.12
Role of immunoblotting in the diagnosis of culture negative and enterococcal endocarditis. J Clin Pathol (1987) 1.09
Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. Eur J Cancer (1991) 1.08
Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptococcus mutans. Infect Immun (1987) 1.05
Active release of bound antibody by Streptococcus mutans. Infect Immun (1995) 1.05
Intranasal immunization of mice with recombinant protein antigen of serotype c Streptococcus mutans and cholera toxin B subunit. Arch Oral Biol (1990) 1.04
Genetic control of immune responses in mice to synthetic peptides of a Streptococcus mutans surface protein antigen. Infect Immun (1992) 1.03
Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am J Med (1990) 1.03
Identification of antigenic epitopes in an alanine-rich repeating region of a surface protein antigen of Streptococcus mutants. Infect Immun (1993) 1.00
Protection of rats against dental caries by passive immunization with hen-egg-yolk antibody (IgY). J Dent Res (1991) 0.96
Effect of immune bovine milk on Streptococcus mutans in human dental plaque. Arch Oral Biol (1991) 0.94
Heat shock protein 88 and Aspergillus infection. J Clin Microbiol (1991) 0.93
The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients. Bone Marrow Transplant (1990) 0.93
Viridans streptococci septicemia in cancer patients: a clinical study. Eur J Epidemiol (1987) 0.91
Cross-reactivity between the immunodominant determinant of the antigen I component of Streptococcus sobrinus SpaA protein and surface antigens from other members of the Streptococcus mutans group. Infect Immun (1990) 0.91
Identification of antigenic epitopes in a surface protein antigen of Streptococcus mutans in humans. Infect Immun (1994) 0.89
Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes. Infect Immun (1994) 0.89
Viridans streptococcal shock in bone marrow transplantation patients. Am J Hematol (1993) 0.89
Alpha-hemolytic streptococci: clinical significance in the cancer patient. Med Pediatr Oncol (1978) 0.87
Epitope mapping of Streptococcus mutans SR protein and human IgG cross-reactive determinants, by using recombinant proteins and synthetic peptides. J Immunol (1992) 0.86
Immunogenicity and antigenicity of a Plasmodium falciparum protein fraction (90-110 kDa) able to protect squirrel monkeys against asexual blood stages. Vaccine (1994) 0.82
Incidence of penicillin tolerance among blood culture isolates of Streptococcus sanguis, 1987-88. J Clin Pathol (1991) 0.81
Serum antibody responses to Streptococcus mutans antigens in humans systemically infected with oral streptococci. Oral Microbiol Immunol (1992) 0.81
Cloning and sequencing the endocarditis immunodominant antigen of Streptococcus sobrinus strain MUCOB 263. J Med Microbiol (1994) 0.80
Epitope mapping human heat shock protein 90 with sera from infected patients. FEMS Immunol Med Microbiol (1994) 0.79
Toxoid vaccine for pertussis. Lancet (1997) 2.43
Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA. J Clin Microbiol (1993) 2.34
Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24
Tandem genes encode cell-surface polypeptides SspA and SspB which mediate adhesion of the oral bacterium Streptococcus gordonii to human and bacterial receptors. Mol Microbiol (1996) 2.21
Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP 90 gene fragment. J Med Microbiol (1993) 2.02
Immunoblot analysis of the serological response in systemic candidosis. Lancet (1984) 1.90
Modulation of T-cell function by gliomas. Immunol Today (1991) 1.78
Immunoblot fingerprinting Aspergillus fumigatus. J Immunol Methods (1989) 1.77
Genetic relatedness of Bordetella species as determined by macrorestriction digests resolved by pulsed-field gel electrophoresis. Int J Syst Bacteriol (1993) 1.76
Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile. J Clin Microbiol (1986) 1.73
An independent assessment of two clubfoot-classification systems. J Pediatr Orthop (1998) 1.66
Restriction endonuclease analysis of Aspergillus fumigatus DNA. J Clin Pathol (1992) 1.65
Is Bordetella pertussis clonal? BMJ (1992) 1.59
Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol (1987) 1.58
The abortion issue: a "battle worth fighting". Tex Med (1992) 1.38
Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis (2000) 1.37
Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J Immunol (1997) 1.31
Cutaneous warts in butchers. Br J Dermatol (1994) 1.24
Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J Infect Dis (1995) 1.20
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia (2001) 1.20
Control of an outbreak of systemic Candida albicans. Br Med J (Clin Res Ed) (1985) 1.19
Butchers' warts: no evidence for person to person transmission of HPV7. Br J Dermatol (1994) 1.11
Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans. J Clin Pathol (1985) 1.10
Role of immunoblotting in the diagnosis of culture negative and enterococcal endocarditis. J Clin Pathol (1987) 1.09
Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. J Immunol (1994) 1.09
Ménétrier's disease and Helicobacter pylori. N Engl J Med (1993) 1.09
Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun (2000) 1.07
Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: comparison with membrane proteins from other bacteria. Infect Immun (1995) 1.04
Immunodiagnosis of invasive fungal infections. J Med Vet Mycol (1994) 1.01
Immunoblot fingerprinting of coagulase negative staphylococci. J Clin Pathol (1988) 1.01
Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis. Eur J Clin Microbiol Infect Dis (1997) 1.01
A comparison of the DNA fragment patterns of the mouse-virulent challenge strains and clinical isolates of Bordetella pertussis. J Infect (1993) 1.00
A comparison of immunoblot and DNA restriction patterns in characterising methicillin-resistant isolates of Staphylococcus aureus. J Med Microbiol (1989) 0.99
An epidemiological study of blood culture isolates of coagulase-negative staphylococci demonstrating hospital-acquired infection. J Clin Microbiol (1997) 0.99
Hospital outbreaks with yeasts. J Hosp Infect (1991) 0.99
How to get the most out of the trainee year. Br Med J (Clin Res Ed) (1982) 0.97
Immunoblot analysis: a new method for fingerprinting hospital pathogens. J Immunol Methods (1987) 0.97
Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections. J Clin Microbiol (1992) 0.97
Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK. Epidemiol Infect (1995) 0.94
Dynamics of the interactions of histones H2A,H2B and H3,H4 with torsionally stressed DNA. Biochemistry (1994) 0.94
Heat shock protein 88 and Aspergillus infection. J Clin Microbiol (1991) 0.93
Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 0.92
Immunoblot analysis of the serological response in invasive Trichosporon beigelii and Blastoschizomyces capitatus infections. J Clin Microbiol (1986) 0.91
Identification of an immunodominant drug efflux pump in Burkholderia cepacia. J Antimicrob Chemother (2002) 0.91
Resting metabolic rate and body composition of achondroplastic dwarfs. Medicine (Baltimore) (1990) 0.89
Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin. Clin Infect Dis (2000) 0.87
A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.84
Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man. J Clin Pathol (1986) 0.84
The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med Mycol (2000) 0.84
Further evidence for an association between a mutation in the APP gene and Lewy body formation. Neurosci Lett (1997) 0.83
Epidural ketamine reduces post-operative epidural PCA consumption of fentanyl/bupivacaine. Can J Anaesth (1998) 0.83
Anaesthesia suitable for prolonged bronchoscopic examination. Thorax (1970) 0.83
Evaluation of an enzyme membrane immunoassay (Directigen RSV) for the rapid diagnosis of respiratory syncytial virus infections. Pathol Biol (Paris) (1991) 0.83
Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas. J Natl Cancer Inst (1987) 0.83
The impact of a grief workshop for pediatric oncology nurses on their grief and perceived stress. J Pediatr Nurs (1994) 0.82
An antibody, in the serum of a Wr(a+) individual, reacting with an antigen of very high frequency. Transfusion (1971) 0.82
The 1996 Leicestershire Community Stroke & Ethnicity Study: differences and similarities between South Asian and white strokes. Int J Epidemiol (1999) 0.82
Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans. J Infect (1987) 0.81
The Bpel locus encodes type III secretion machinery in Bordetella pertussis. Microb Pathog (1999) 0.80
PCR fingerprinting microbes by random amplification of polymorphic DNA. J Med Microbiol (1993) 0.80
Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec. Can Commun Dis Rep (1993) 0.80
Perceptions of community services among Asian and white stroke survivors and their carers: an exploratory study. Ethn Health (2000) 0.80
Epitope mapping Candida albicans proteinase (SAP 2). FEMS Immunol Med Microbiol (1997) 0.80
Defining potential targets for immunotherapy in Burkholderia cepacia infection. FEMS Immunol Med Microbiol (1995) 0.79
A preliminary investigation of chlorinated hydrocarbons and chronic fatigue syndrome. Med J Aust (1995) 0.79
Epitope mapping human heat shock protein 90 with sera from infected patients. FEMS Immunol Med Microbiol (1994) 0.79
Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination. Cell Mol Neurobiol (1992) 0.79
A polymerase chain reaction enzyme immunoassay for diagnosing infection caused by Aspergillus fumigatus. J Clin Pathol (1999) 0.78
Rocuronium priming of atracurium-induced neuromuscular blockade: the use of short priming intervals. J Clin Anesth (1996) 0.78
Inhaled CO2 and progressive hypoxia: ventilatory response in a yearling and a newborn harbor seal. Life Sci II (1973) 0.78
Effects of a period of asphyxia during birth on spatial learning in the rat. Pediatr Res (1995) 0.77
Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade. Anesthesiology (1993) 0.77
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting. J Infect (2000) 0.77
An evaluation of the emerging vaccines against influenza in children. BMC Public Health (2013) 0.77
Quantification of Escherichia coli genomic DNA contamination in recombinant protein preparations by polymerase chain reaction and affinity-based collection. Anal Biochem (2001) 0.77
Characterization of the antibody response in Corynebacterium jeikeium septicaemias. Epidemiol Infect (1990) 0.77
Measurement of single- and double-spin asymmetries in deep inelastic pion electroproduction with a longitudinally polarized target. Phys Rev Lett (2010) 0.76
Transmission of pertussis: do adults have an important role? Lancet (1996) 0.76
The renaissance of antibody therapy. J Antimicrob Chemother (1998) 0.76
Do older patients receive adequate stroke care? An experience of a neurovascular clinic. Postgrad Med J (2009) 0.76
The effect of an accelerated immunisation schedule on pertussis in England and Wales. Commun Dis Rep CDR Rev (1996) 0.76
Can pre-emptive interpleural block reduce perioperative anesthetic and analgesic requirements? Reg Anesth (1995) 0.76
Cost-effectiveness of colorectal cancer screening. JAMA (2001) 0.75
Immunological and bacteriological distinction between parapertussis and pertussis. Lancet (1995) 0.75
Efficacy of glucosamine and chondroitin for treatment of osteoarthritis. JAMA (2000) 0.75
Components of acellular pertussis vaccines. Lancet (1996) 0.75
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising. JAMA (1997) 0.75
Chlorinated hydrocarbons and chronic fatigue syndrome. Med J Aust (1996) 0.75
Pertussis vaccination. Lancet (1993) 0.75
Feasibility study of CPR in the water. Undersea Biomed Res (1980) 0.75
Acellular pertussis vaccines: progress but déjà vu. Lancet (1998) 0.75
Bioaccumulated chlorinated hydrocarbons and red/white blood cell parameters. Biochem Mol Med (1996) 0.75
Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2. Cell Mol Neurobiol (1993) 0.75
Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults. Br J Anaesth (1996) 0.75
The privatization of the civil commitment process and the state action doctrine: have the mentally ill been systematically stripped of their Fourteenth Amendment rights? Duquesne Law Rev (2001) 0.75
New techniques in external cardiac compressions. Aquatic cardiopulmonary resuscitation. JAMA (1980) 0.75
Blood flow measurement by Doppler ultrasound: a question of angles. Phys Med Biol (1993) 0.75